[PDF][PDF] Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis

Ł Szarpak, B Nowak, D Kosior, A Zaczynski… - Pol Arch Intern …, 2021 - researchgate.net
To the Editor, We read with great interest articles Kosmaczewska et al.[1] and Marcinkiewicz
et al.[2], showing the potential role of cytokines, including interleukin-6, as a predictor of …

[HTML][HTML] From acute SARS-CoV-2 infection to pulmonary hypertension

E Eroume À Egom, HA Shiwani, B Nouthe - Frontiers in Physiology, 2022 - frontiersin.org
As the world progressively recovers from the acute stages of the coronavirus disease 2019
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …

[HTML][HTML] Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19

B Liao, Z Liu, L Tang, L Li, Q Gan, H Shi… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Rationale: Previous studies of coronavirus disease 2019 (COVID-19) were mainly focused
on cross-sectional analysis. In this study, we sought to evaluate the dynamic changes of …

[HTML][HTML] Demystifying excess immune response in COVID-19 to reposition an orphan drug for down-regulation of NF-κB: a systematic review

A Peddapalli, M Gehani, AM Kalle, SR Peddapalli… - Viruses, 2021 - mdpi.com
The immunological findings from autopsies, biopsies, and various studies in COVID-19
patients show that the major cause of morbidity and mortality in COVID-19 is excess immune …

[HTML][HTML] Comprehensive cytokine profiling of patients with covid-19 receiving tocilizumab therapy

A Lebedeva, I Molodtsov, A Anisimova… - International journal of …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is characterized by immune activation in response to
viral spread, in severe cases leading to the development of cytokine storm syndrome (CSS) …

Effects of Immune System‐Related Medications on COVID‐19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study

E Bitaraf, SAY Ahmadi… - Journal of …, 2021 - Wiley Online Library
Background. Regulation of the immune system is critical for fighting against viral infections.
Both suppression and hyperactivity of the immune system result in failure of treatment. The …

[PDF][PDF] Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes

J Marcinkiewicz, H Mazurek, G Majka… - … = Polish Archives of …, 2020 - ruj.uj.edu.pl
POLISH ARCHIVES OF INTERNAL MEDICINE 2020; 130 (10) 920 no symptoms or develop
mild disease; death is rare and most often associated with oral corti costeroid administration …

The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system

J Marcinkiewicz, JM Witkowski… - Central European Journal …, 2021 - termedia.pl
COVID-19 is a highly contagious respiratory disease caused by the novel coronavirus SARS-
CoV-2. Since October 2020 the second wave of the pandemic has been observed around …

[HTML][HTML] Effect of pharmaceutical care on the treatment of Covid-19: A protocol for systematic review and meta analysis

J Niu, H Chen, K Chen, Y Liu, F Ju, T Xue, D Yin, C Li… - Medicine, 2020 - journals.lww.com
Background: We aimed to conduct a meta-analysis to assess the effect of pharmaceutical
care on the treatment of coronavirus disease 2019 (COVID-19). Methods: All case-controlled …

SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses

Y Zhao, L Sui, P Wu, W Wang, G Tan, Z Wang, Y Yu… - bioRxiv, 2021 - biorxiv.org
The recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of the ongoing global pandemic of COVID-19, may trigger …